Additional testing should include more examples of each type of tested cancers as well as an expanded investigation into all epithelial cancers, with the caveat that matriptase expression, and therefore this window into ROS-mediated survival, is lacking in more mesenchymal-like cancers. This evidence concerns the gene ST14 and cancer.